for the period from January 1 to December 31, 2021
|
|
Note |
2021 |
2020 |
|---|---|---|---|---|
Net profit/loss for the year |
|
127,714 |
(10,595) |
|
+ |
Amortization of intangible assets and depreciation of property, plant and equipment and right-of-use assets |
164,269 |
160,448 |
|
+/– |
Change in the fair value of biological assets |
(2,258) |
10,334 |
|
– |
Income from the release of investment grants |
|
(1,944) |
(1,979) |
+/– |
Change in non-current provisions |
|
(4,908) |
(5,394) |
–/+ |
Income / expenses from deferred taxes |
|
6,838 |
10,768 |
+/– |
Change in current tax assets and liabilities |
|
42,727 |
(15,299) |
+/– |
Income from investments accounted for using the equity method |
|
4,431 |
(4,883) |
–/+ |
Other non-cash income / expenses |
35,128 |
(16,568) |
|
Gross cash flow |
|
371,999 |
126,831 |
|
|
|
|
|
|
+/– |
Change in inventories |
|
(144,902) |
81,439 |
+/– |
Change in receivables |
|
(75,115) |
(38,360) |
+/– |
Change in liabilities |
|
242,049 |
(120,965) |
Change in working capital |
|
22,032 |
(77,885) |
|
Cash flow from operating activities |
|
394,030 |
48,946 |
|
|
|
|
|
|
– |
Acquisition of intangible assets, property, plant and equipment and biological assets (CAPEX) |
|
(844,333) |
(668,760) |
– |
Acquisition of financial assets and investments accounted for using the equity method |
|
(7,328) |
(4,050) |
+ |
Proceeds from the sale of intangible assets, property, plant and equipment and biological assets |
|
4,810 |
5,046 |
+ |
Proceeds from the sale/repayment of financial assets and the sale of investments accounted for using the equity method |
|
5,567 |
1,546 |
Cash flow from investing activities |
|
(841,285) |
(666,219) |
|
|
|
|
|
|
+ |
Capital injections to consolidated companies by non-controlling interests |
|
15,577 |
84,458 |
+ |
Increase of hybrid capital |
0 |
495,443 |
|
– |
Dividends paid (including hybrid coupon) |
(28,925) |
(200) |
|
+ |
Investment grants |
|
1,095 |
1,618 |
+ |
Increase of bonds and private placements |
0 |
131,691 |
|
+ |
Increase in other financial liabilities |
626,384 |
604,277 |
|
– |
Repayment of bonds and private placements |
(56,000) |
(37,500) |
|
– |
Repayment of other financial liabilities |
(87,584) |
(144,691) |
|
Cash flow from financing activities |
|
470,548 |
1,135,096 |
|
|
|
|
|
|
Total change in liquid funds |
|
23,293 |
517,823 |
|
|
|
|
|
|
Liquid funds at the beginning of the year |
|
1,069,998 |
571,479 |
|
Currency translation adjustment relating to liquid funds |
|
19,987 |
(19,304) |
|
Liquid funds at the end of the year |
|
1,113,279 |
1,069,998 |
|
|
|
|
|
|
Additional information on payments in the cash flow from operating activities: |
|
|
|
|
Interest payments received |
|
3,963 |
1,742 |
|
Interest payments made |
|
34,315 |
19,449 |
|
Income taxes paid |
|
9,087 |
33,533 |
|
Distributions received from investments accounted for using the equity method |
|
890 |
40 |
|